Soluble CD24 is an inflammatory biomarker in early and seronegative rheumatoid arthritis

Author:

Zheng Xi12,Wang Ping1,Song Jing12,Tang Yundi1,Xie Yang1,Jin Xu12,Zhu Danxue12,Fang Xiangyu1,Wei Chaonan1,Li Ru1,Hu Fanlei134,Li Zhanguo123

Affiliation:

1. Department of Rheumatology and Immunology, Peking University People’s Hospital & Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis, Beijing, China

2. Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China

3. State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China

4. Department of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University, Beijing, China

Funder

National Natural Science Foundation of China

Beijing Nova Program

Peking University Clinical Medicine Plus X-Young Scholars Project

Peking University People’s Hospital Research and Development Funds

Publisher

Informa UK Limited

Subject

General Medicine

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Checkpoint CD24 function on tumor and immunotherapy;Frontiers in Immunology;2024-02-29

2. Surprising magic of CD24 beyond cancer;Frontiers in Immunology;2024-01-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3